Hennlich Healthcare (03309.HK) Reports Full-Year 2023 Results: Net Profit Attributable to Shareholders Reaches HK$61.998 Million, Turning Around from Previous Year's Loss

C-MER Medical (03309) announced its annual results for the year ended December 31, 2023, with revenue of HKD 1.924 billion, representing a year-on-year increase of 11.1%. Profit attributable to equity holders of the company for the year amounted to HKD 61.998 million, compared to a loss of HKD 21.875 million for the same period in 2022. Earnings per share were 4.94 Hong Kong cents.

The announcement stated that the total revenue in 2023 was HKD 1.924 billion, a slight increase of 11.1% compared to 2022. This was due to the record-high core medical service revenue (including ophthalmology services, dental and other medical services, and sales of vision aids), which grew by 32.9% from HKD 1.434 billion in 2022 to HKD 1.905 billion in 2023. However, this growth was partially offset by a 93.5% decrease in revenue from the sale of COVID-19 related medical consumables, which dropped to HKD 19.4 million in 2023.